Reporting owner · CIK 0001723524
Sherman Darren
Visual SEC Form 4 history across 1 companies, 7 transactions and 6 filings.
SRSee RemarksOrchestra BioMed Holdings, Inc.
Open-market mix
50%buys
Open-market buy performance
90-day forward return on this insider's open-market purchases
Forward return is not available yet
We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for some of their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.
Monthly open-market activity
Reported purchase and sale transaction counts
Buys Sells
Net value flow
Buys minus sells
Jan 26
$0
Feb 26
$0
May 26
$0
Aug 26
$10.7K
Sep 26
−$74.1K
Transaction texture
Ownership and ticket size
Average P/S size$42.4K
Median P/S size$42.4K
Direct6
Indirect1
Sep 01, 2026sale
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
Latest transaction
sale at Orchestra BioMed Holdings, Inc. on Sep 01, 2026 valued at $74,100.
Review SEC filingLatest buy
buy at Orchestra BioMed Holdings, Inc. on Aug 26, 2026 valued at $10,660.
Review SEC filingLatest sale
sale at Orchestra BioMed Holdings, Inc. on Sep 01, 2026 valued at $74,100.
Review SEC filingAssociated companies
Visual map of known reporting history
| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| OBIO | Sherman Darren | SR | sale10b5-1 | 15.0k | -$7.41M | S | 0.0% | 09/02 | 09/01 | |
| OBIO | Sherman Darren | SR | buy | 2.00k | $1.06M | P | — | 08/28 | 08/26 | |
| OBIO | Sherman Darren | SR | withholding | 4.92k | -$2.59M | F | — | 08/28 | 08/26 | |
| OBIO | Sherman Darren | SR | withholding | 4.92k | -$1.96M | F | +38.4% | 05/29 | 05/28 | |
| OBIO | Sherman Darren | SR | grant | 397k | $0 | A | +7.3% | 02/13 | 02/12 | |
| OBIO | Sherman Darren | SR | grant | 34.9k | $0 | A | +0.5% | 02/06 | 01/28 | |
| OBIO | Sherman Darren | SR | withholding | 5.58k | -$2.40M | F | +0.9% | 01/02 | 01/02 |
Sherman Darren Insider Activity FAQ
SEC Form 4 context
Who is Sherman Darren?
Sherman Darren is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001723524.
Which companies has Sherman Darren reported transactions for?
Orchestra BioMed Holdings, Inc.
When was Sherman Darren's latest insider buy?
buy at Orchestra BioMed Holdings, Inc. on Aug 26, 2026 valued at $10,660.
When was Sherman Darren's latest insider sale?
sale at Orchestra BioMed Holdings, Inc. on Sep 01, 2026 valued at $74,100.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.